Financial Contrast: Joint (JYNT) vs. Its Rivals

Joint (NASDAQ:JYNT) is one of 233 public companies in the “Healthcare Providers & Services” industry, but how does it contrast to its peers? We will compare Joint to similar businesses based on the strength of its risk, institutional ownership, earnings, analyst recommendations, valuation, profitability and dividends.

Profitability

This table compares Joint and its peers’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Joint	6.49%	12.02%	3.47%
Joint Competitors	-7.69%	-141.09%	-1.47%

Analyst Recommendations

This is a summary of recent recommendations and price targets for Joint and its peers, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Joint	1	1	0	0	1.50
Joint Competitors	1859	7720	13326	819	2.55

As a group, “Healthcare Providers & Services” companies have a potential upside of 14.55%. Given Joint’s peers stronger consensus rating and higher possible upside, analysts plainly believe Joint has less favorable growth aspects than its peers.

Institutional & Insider Ownership

76.9% of Joint shares are owned by institutional investors. Comparatively, 56.7% of shares of all “Healthcare Providers & Services” companies are owned by institutional investors. 30.2% of Joint shares are owned by insiders. Comparatively, 15.0% of shares of all “Healthcare Providers & Services” companies are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Earnings & Valuation

This table compares Joint and its peers top-line revenue, earnings per share and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
Joint	$54.90 million	$2.91 million	25.37
Joint Competitors	$21.02 billion	$288.54 million	12.92

Joint’s peers have higher revenue and earnings than Joint. Joint is trading at a higher price-to-earnings ratio than its peers, indicating that it is currently more expensive than other companies in its industry.

Risk and Volatility

Joint has a beta of 1.16, suggesting that its stock price is 16% more volatile than the S&P 500. Comparatively, Joint’s peers have a beta of 0.98, suggesting that their average stock price is 2% less volatile than the S&P 500.

Summary

Joint beats its peers on 7 of the 13 factors compared.

About Joint

The Joint Corp. operates and franchises chiropractic clinics in the United States. The company operates in two segments, Corporate Clinics and Franchise Operations. The Joint Corp. was incorporated in 2010 and is headquartered in Scottsdale, Arizona.